Eli Lilly launches new, cheaper form of weight-loss drug
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City on December 11, 2023. Brendan…
Eli Lilly and company
Eli Lilly weight-loss drug reduces diabetes risk in trial
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Weight loss drugs from Eli Lilly and Novo Nordisk
A Zepbound injection pen from Eli Lilly & Co., March 28, 2024. Bloomberg | Bloomberg | Getty Images Do you…
Ro launches GLP-1 insurance coverage checker
Zoom iconArrows pointing outwards Direct-to-consumer healthcare startup Ro on Tuesday launched a new, free tool to help patients determine whether…
Eli Lilly (LLY) Q2 2024 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, September 17, 2020. Mike…
What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
FDA says Eli Lilly's Zepbound and Mounjaro are available after shortage
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
Eli Lilly's Zepbound weight-loss drug cuts heart failure risks, study finds
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
GLP-1s are being tested for uses beyond weight loss and diabetes
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…